MHRA – Page 191 – Pharma.Tips

Pet Failure in suppository manufacturing: GMP investigation and batch disposition

GMP Investigation of Pet Failure in Suppository Manufacturing: A Comprehensive Approach Pharmaceutical manufacturing is a complex process requiring stringent adherence to Good Manufacturing Practices (GMP). A deviation in suppository production,…

Cooling Tunnel Variability after temperature excursion: manufacturing vs lab root cause decision tree

Understanding Cooling Tunnel Variability After Temperature Excursion: A Root Cause Investigation Approach The integrity of pharmaceutical manufacturing processes is paramount, particularly when ensuring consistent product quality and compliance with regulatory…

Particulate Matter Oos at stability pull: sampling, filtration, and EM controls

Addressing OOS for Particulate Matter at Stability Pull: An Investigation Framework In quality-driven environments like pharmaceutical manufacturing, deviations such as Out of Specification (OOS) results for particulate matter during stability…

Melting Point Failure in vaginal gel production: CAPA with effectiveness checks for auditors

Investigation of Melting Point Failures in the Production of Vaginal Gels: A CAPA Approach The pharmaceutical manufacturing industry continuously faces challenges in ensuring product quality and compliance with regulatory standards.…

Cleaning Validation Failure during cooling and moulding: manufacturing vs lab root cause decision tree

Root Cause Investigation of Cleaning Validation Failures during Cooling and Moulding Processes Cleaning validation failures during the cooling and moulding phases often lead to significant deviations in pharmaceutical manufacturing, particularly…

Suppository Deformation in suppository manufacturing: CAPA with effectiveness checks for auditors

Addressing Suppository Deformation in Manufacturing: Effective CAPA Approaches for Compliance Suppository deformation during manufacturing is a critical issue that can have significant implications for product quality, safety, and regulatory compliance.…

Media Fill Failure after packaging change: risk assessment for sterility assurance

Addressing Media Fill Failures Prompted by Packaging Changes: A Comprehensive Investigation Failures in media fill tests can have significant implications for sterility assurance in pharmaceutical manufacturing, especially after a packaging…

Fill Weight Variability during inspection readiness: CAPA with effectiveness checks for auditors

Addressing Fill Weight Variability during Inspection Readiness: A Comprehensive CAPA Approach In the pharmaceutical manufacturing landscape, achieving consistent fill weights is essential for compliance and product integrity. Variability in fill…

Pet Failure during cooling and moulding: CAPA with effectiveness checks for auditors

Understanding and Addressing Pet Failure during Cooling and Moulding in Pharmaceutical Manufacturing In pharmaceutical manufacturing, particularly in the production of dosage forms like rectal and vaginal preparations, pet failures during…

Ccit Failure during sterile filtration: FDA-ready investigation report and batch disposition

Ccit Failure in Sterile Filtration: A Comprehensive Investigation Guide In the world of pharmaceutical manufacturing, maintaining the integrity of processes such as sterile filtration is crucial, particularly in ophthalmic dosage…

Microbial Limits Failure after excipient change: packaging integrity and stability justification

Investigation of Microbial Limits Failures Following an Excipient Change In the pharmaceutical manufacturing space, excipient changes can precipitate unforeseen microbial limits failures, prompting concerns about product safety and compliance. This…

Viscosity Drift during bulk hold: packaging integrity and stability justification

Understanding and Addressing Viscosity Drift Issues during Bulk Hold in Pharmaceutical Manufacturing In the context of pharmaceutical manufacturing, viscosity drift during the bulk hold stage can be a critical concern,…